Back
Allegiant Travel 10K Form
Buy
60
ALGT
Allegiant Travel
Last Price:
66.22
Seasonality Move:
9.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | ALGT/Allegiant Travel Quarterly |
2024-03-08 | 10K | ALGT/Allegiant Travel Annual |
2024-02-29 | 10K | ALGT/Allegiant Travel Annual |
2023-11-08 | 10Q | ALGT/Allegiant Travel Quarterly |
2023-08-07 | 10Q | ALGT/Allegiant Travel Quarterly |
2023-05-08 | 10Q | ALGT/Allegiant Travel Quarterly |
Receive ALGT News And Ratings
See the #1 stock for the next 7 days that we like better than ALGT
ALGT Financial Statistics
Sales & Book Value
Annual Sales: | $2.51B |
---|---|
Cash Flow: | $7.03M |
Price / Cash Flow: | 0 |
Annual Sales: | $71.05 |
Price / Book: | 0.93 |
Profitability
EPS (TTM): | -1.50000 |
---|---|
Net Income (TTM): | $-25.97M |
Gross Margin: | $497.74M |
Return on Equity: | -1.96% |
Return on Assets: | -0.53% |
Allegiant Travel Earnings Forecast
Key Allegiant Travel Financial Ratios
- The Gross Profit Margin over the past 20 years for ALGT is 19.83%.
- The Selling, General & Administrative Expenses for ALGT have been equal to 4.57% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 91.89% of Operating Income.
- The Net Earning history of ALGT is 4.69% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 13 years.
Allegiant Travel Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Passenger Airlines |
Sector: | Industrials |
Current Symbol: | ALGT |
CUSIP: | 01748X |
Website: | allegiant.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0.74 |
Quick Ratio: | 0.66 |
Price-to-Earnings
Trailing P/E Ratio: | 10.53 |
---|---|
Forward P/E Ratio: | 12.11 |
ALGT Technical Analysis vs Fundamental Analysis
Buy
60
Allegiant Travel (ALGT)
is a Buy
Is Allegiant Travel a Buy or a Sell?
-
Allegiant Travel stock is rated a Buy
The current Allegiant Travel [ALGT] share price is $66.25. The Score for ALGT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.